Author

Heather Moore

Institutions: Duke University, Duke Cancer Institute

Observed institutions: Duke University, Duke Cancer Institute

OpenAlex ID: A5129013976

Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer

2026 · Paolo Tarantino, Se-Eun Kim, et al. · npj Precision Oncology · 9

Cardiovascular Toxicity of Antibody-Drug Conjugates in Breast Cancer

2026 · Heather Moore, Laura A. Huppert, et al. · JACC CardioOncology · 2

Works count: 2

Citation count: 11

H-index: 2

I10-index: